EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors

Stefano Zoroddu, Luca Sanna, Valentina Bordoni, Lyu Weidong, Sergio Domenico Gadau iD, Antonio Carta, David J Kelvin, Luigi Bagella iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25115704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Stefano Zoroddu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy. Hauptthemen laut MEDLINE: Microtubules, Antineoplastic Agents, Acrylonitrile. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Finanziato dall’Unione europea—NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, a compound derived from recent scientific advances named 34 has emerged as the focus of this research, the aim of which is to explore its potential impact on solid tumor cell lines. Using a combination of bioinformatics and biological assays, this study conducted an in-depth investigation of the effects of 34. The results of this study have substantial implications for cancer research and treatment. 34 has shown remarkable efficacy in inhibiting the growth of several cancer cell lines, including those representing prostate carcinoma (PC3) and cervical carcinoma (HeLa). The high sensitivity of these cells, indicated by low IC50 values, underscores its potential as a promising chemotherapeutic agent. In addition, 34 has revealed the ability to induce cell cycle arrest, particularly in the G2/M phase, a phenomenon with critical implications for tumor initiation and growth. By interfering with DNA replication in cancer cells, 34 has shown the capacity to trigger cell death, offering a new avenue for cancer treatment. In addition, computational analyses have identified key genes affected by 34 treatment, suggesting potential therapeutic targets. These genes are involved in critical biological processes, including cell cycle regulation, DNA replication and microtubule dynamics, all of which are central to cancer development and progression. In conclusion, this study highlights the different mechanisms of 34 that inhibit cancer cell growth and alter the cell cycle. These promising results suggest the potential for more effective and less toxic anticancer therapies. Further in vivo validation and exploration of combination therapies are critical to improve cancer treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrotubulesAntineoplastic AgentsAcrylonitrileHumansCell Line, TumorCell ProliferationNeoplasmsHeLa CellsApoptosisTriazolesCell Cycle CheckpointsTubulin ModulatorsPC-3 Cells

Stichwörter der Autor:innen

MTARNAseqcancermicrotubulessolid tumors

Substanzen

Antineoplastic AgentsAcrylonitrileTriazolesTubulin Modulators

Autor:innen und Institutionen

  • Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
  • Division of Immunology, International Institute of Infection and Immunity, Shantou University Medical College, Shantou 515031, China.
  • Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy.
  • Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
  • Department of Microbiology and Immunology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
  • Sbarro Institute for Cancer Research and Molecular Medicine, Centre for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.

ORCID-Profile: Sergio Domenico Gadau, Luigi Bagella

Förderung

  • Finanziato dall’Unione europea—NextGenerationEU

Zitieren

APA

Zoroddu, S., Sanna, L., Bordoni, V., Weidong, L., Gadau, S. D., Carta, A., Kelvin, D. J., & Bagella, L. (2024). Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115704

Vancouver

Zoroddu S, Sanna L, Bordoni V, Weidong L, Gadau SD, Carta A, et al. Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115704

BibTeX
@article{Zoroddu2024,
  author = {Zoroddu, Stefano and Sanna, Luca and Bordoni, Valentina and Weidong, Lyu and Gadau, Sergio Domenico and Carta, Antonio and Kelvin, David J and Bagella, Luigi},
  title = {Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25115704}
}
Kostenlos starten →